Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10315992 Tetracyline compounds

Patent 10315992 was granted and assigned to Tetraphase Pharmaceuticals on June, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Tetraphase Pharmaceuticals

Current Assignee

Tetraphase Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10315992

Date of Patent

June 11, 2019

Patent Application Number

15400674

Date Filed

January 6, 2017

Patent Citations

‌

US Patent 10072007 Tetracycline compounds

Patent Citations Received

‌

US Patent 10961190 Crystalline forms of eravacycline

‌

US Patent 10913712 Tetracycline compounds

‌

US Patent 11578044 Crystalline forms of eravacycline

Patent Primary Examiner

‌

Amanda L. Aguirre

Patent abstract

The present invention is directed to a compound represented by Structural Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10315992 Tetracyline compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API